BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, Chen YB, Sun XW, Chen G, Liu Q. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-326. [PMID: 19050970 DOI: 10.1245/s10434-008-0240-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Kano K, Yamada T, Oshima T. ASO Author Reflections: Association Between the Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Ann Surg Oncol 2020;27:4248-9. [PMID: 32462524 DOI: 10.1245/s10434-020-08666-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 El Hanafy E, El Nakeeb A, Ezzat H, Hamdy E, Atif E, Kandil T, Fouad A, Wahab MA, Monier A. How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience. World J Gastrointest Surg 2016; 8(6): 444-451 [PMID: 27358677 DOI: 10.4240/wjgs.v8.i6.444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kong F, Gao F, Chen J, Zheng R, Liu H, Li X, Yang P, Liu G, Jia Y. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer. Oncotarget 2016;7:55765-70. [PMID: 27303917 DOI: 10.18632/oncotarget.9910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhou Y, Zhang J, Cao S, Li Y. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309-317. [PMID: 22945599 DOI: 10.1007./s10120-012-0190-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Cao H, Tang Z, Yu Z, Wang Q, Li Z, Lu Q, Wu Y. Comparison of the 8th union for international cancer control lymph node staging system for gastric cancer with two other lymph node staging systems. Oncol Lett 2019;17:1299-305. [PMID: 30655898 DOI: 10.3892/ol.2018.9694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Kim J, Kim M, Oh D, Lee S, Kim D, Im S, Kim WH, Yang H, Heo DS, Bang Y, Lee K, Kim T. Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study. Japanese Journal of Clinical Oncology 2011;41:245-52. [DOI: 10.1093/jjco/hyq215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, Lauwers GY, Yoon SS. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255:478-485. [PMID: 22330040 DOI: 10.1097/sla.0b013e31824857e2] [Cited by in Crossref: 137] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
8 Zhang JW, Chu YM, Lan ZM, Tang XL, Chen YT, Wang CF, Che X. Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol 2015; 21(14): 4255-4260 [PMID: 25892876 DOI: 10.3748/wjg.v21.i14.4255] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R. Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes. Ann Med Surg (Lond) 2016;6:36-41. [PMID: 27141301 DOI: 10.1016/j.amsu.2016.01.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
11 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One. 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Díaz Del Arco C, Estrada Muñoz L, Sánchez Pernaute A, Ortega Medina L, García Gómez de Las Heras S, García Martínez R, Fernández Aceñero MJ. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer. Ann Diagn Pathol 2021;52:151738. [PMID: 33865185 DOI: 10.1016/j.anndiagpath.2021.151738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. European Journal of Surgical Oncology (EJSO) 2017;43:1350-6. [DOI: 10.1016/j.ejso.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
14 Chen S, Rao H, Liu J, Geng Q, Guo J, Kong P, Li S, Liu X, Sun X, Zhan Y, Xu D. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes. Oncotarget 2017;8:45585-96. [PMID: 28489596 DOI: 10.18632/oncotarget.17276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
15 Lee YC, Yang PJ, Zhong Y, Clancy TE, Lin MT, Wang J. Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry. Am J Clin Oncol 2017;40:35-41. [PMID: 25089533 DOI: 10.1097/COC.0000000000000110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
16 Jiao X, Wang Y, Wang F, Wang X. Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy. Medicine (Baltimore) 2020;99:e23795. [PMID: 33371151 DOI: 10.1097/MD.0000000000023795] [Reference Citation Analysis]
17 Catarci M, Montemurro LA, Di Cintio A, Ghinassi S, Coppola L, Pinnarelli L, Belardi A, Koch M, Grassi GB. Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution. Updates Surg. 2010;62:89-99. [PMID: 20845010 DOI: 10.1007/s13304-010-0017-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
18 Cidón EU. Gastric cancer and the search for a good prognostic classification: a challenge. Clin Exp Gastroenterol 2010;3:113-6. [PMID: 21694854 DOI: 10.2147/ceg.s11929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
19 Zhou R, Zhang J, Sun H, Liao Y, Liao W. Comparison of three lymph node classifications for survival prediction in distant metastatic gastric cancer. Int J Surg 2016;35:165-71. [PMID: 27713088 DOI: 10.1016/j.ijsu.2016.09.096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
20 Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277. [PMID: 20099040 DOI: 10.1245/s10434-010-0914-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
21 Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, Zhou ZW, Zhan YQ, Qian CN, Chen YB. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One 2012;7:e49424. [PMID: 23166665 DOI: 10.1371/journal.pone.0049424] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
22 Mocellin S, Pasquali S, Riccardo Rossi C, Nitti D. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: A population-based study of 8,177 cases. Surgery 2011;150:83-90. [DOI: 10.1016/j.surg.2011.02.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
23 Rausei S, Galli F, Lianos G, Rosa F, Cossu A, Biondi A, Martignoni F, Cananzi FCM, Fumagalli U, Alfieri S, Persiani R, Quagliuolo V, D'Ugo D, Rosati R. How Should We Measure the Quality of Lymphadenectomy for Gastric Cancer? Anatomical Versus Numerical Criterion. J Gastrointest Cancer 2020;51:887-92. [PMID: 31691087 DOI: 10.1007/s12029-019-00321-x] [Reference Citation Analysis]
24 Zhou Y, Zhang J, Cao S, Li Y. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309-317. [PMID: 22945599 DOI: 10.1007/s10120-012-0190-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
25 Seevaratnam R, Bocicariu A, Cardoso R, Yohanathan L, Dixon M, Law C, Helyer L, Coburn NG. How many lymph nodes should be assessed in patients with gastric cancer? Gastric Cancer. 2012;15 Suppl 1:S70-S88. [PMID: 22895615 DOI: 10.1007/s10120-012-0169-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
26 Huang Z, Chen Y, Zhang W, Liu H, Wang Z, Zhang Y. Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study. Ann Surg Oncol 2020;27:1480-7. [DOI: 10.1245/s10434-019-08098-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Lorenzon L, Mercantini P, Ferri M, La Torre M, Sparagna A, Balducci G, Tarantino G, Romiti A, Pilozzi E, Ziparo V. Profiling the prognosis of gastric cancer patients: is it worth correlating the survival with the clinical/pathological and molecular features of gastric cancers? ScientificWorldJournal 2013;2013:196541. [PMID: 24453810 DOI: 10.1155/2013/196541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Cheng CY, Sun FJ, Liu CJ. The influence of cervical lymph node number of neck dissection on the prognosis of the early oral cancer patients. J Dent Sci 2020;15:519-25. [PMID: 33505625 DOI: 10.1016/j.jds.2020.06.002] [Reference Citation Analysis]
29 Sianesi M, Bezer L, Del Rio P, Dell’Abate P, Iapichino G, Soliani P, Tacci S. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:614-619. [PMID: 20101526 DOI: 10.1007/s11605-009-1142-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
30 Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255:50-58. [PMID: 21577089 DOI: 10.1097/sla.0b013e31821d4d75] [Cited by in Crossref: 94] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
31 Wang W, Xu D, Li Y, Guan Y, Sun X, Chen Y, Kesari R, Huang C, Li W, Zhan Y, Zhou Z. Tumor–ratio–metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection—results of a single-institution study of 1343 Chinese patients. Annals of Oncology 2011;22:2049-56. [DOI: 10.1093/annonc/mdq716] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
32 de Bree E, Charalampakis V, Melissas J, Tsiftsis DD. The extent of lymph node dissection for gastric cancer: a critical appraisal. J Surg Oncol. 2010;102:552-562. [PMID: 20976727 DOI: 10.1002/jso.21646] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
33 Cidón EU. A different variable to stratify risk in resected gastric cancer. Ann Surg Oncol 2010;17:657-8. [PMID: 19882187 DOI: 10.1245/s10434-009-0791-z] [Reference Citation Analysis]
34 Pedrazzani C, Sivins A, Ancans G, Marrelli D, Corso G, Krumins V, Roviello F, Leja M. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2010;34:85-91. [PMID: 20020295 DOI: 10.1007/s00268-009-0288-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
35 Zhu J, Xue Z, Zhang S, Guo X, Zhai L, Shang S, Zhang Y, Lu H. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis. Int J Surg 2018;57:76-83. [PMID: 30103072 DOI: 10.1016/j.ijsu.2018.08.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
36 Catarci M, Montemurro LA, Ghinassi S, Di Cintio A, Leone L, Cosentino LM, Viarengo MA, Grassi GB. Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer. Updates Surg. 2011;63:83-90. [PMID: 21445644 DOI: 10.1007/s13304-011-0065-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Xue L, Chen XL, Zhang WH, Yang K, Chen XZ, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Risk factors and prognostic significance of retropancreatic lymph nodes in gastric adenocarcinoma. Gastroenterol Res Pract 2015;2015:367679. [PMID: 25642243 DOI: 10.1155/2015/367679] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Kong F, Qi Y, Liu H, Gao F, Yang P, Li Y, Jia Y. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis. Clin Transl Oncol 2015;17:917-24. [PMID: 26088414 DOI: 10.1007/s12094-015-1327-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
39 Aurello P, Petrucciani N, Nigri GR, La Torre M, Magistri P, Tierno S, D'Angelo F, Ramacciato G. Log odds of positive lymph nodes (LODDS): what are their role in the prognostic assessment of gastric adenocarcinoma? J Gastrointest Surg 2014;18:1254-60. [PMID: 24841441 DOI: 10.1007/s11605-014-2539-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
40 Eom BW, Joo J, Kim YW, Reim D, Park JY, Yoon HM, Ryu KW, Lee JY, Kook MC. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery. 2014;155:408-416. [PMID: 24287148 DOI: 10.1016/j.surg.2013.08.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
41 Petrelli F, Borgonovo K, Barni S. The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: An overview of literature. European Journal of Surgical Oncology (EJSO) 2011;37:836-47. [DOI: 10.1016/j.ejso.2011.07.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
42 Qian J, Qian Y, Wang J, Gu B, Pei D, He S, Zhu F, Røe OD, Xu J, Liu L, Gu Y, Guo R, Yin Y, Shu Y, Chen X. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy. Drug Des Devel Ther 2016;10:241-58. [PMID: 26966350 DOI: 10.2147/DDDT.S88743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
43 Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, Seo HS, Jung YJ, Park JM, Lee SH, Roh SY, Kim IH. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer 2019;19:1232. [PMID: 31852475 DOI: 10.1186/s12885-019-6433-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 D'Ugo D, Agnes A, Grieco M, Biondi A, Persiani R. Global updates in the treatment of gastric cancer: a systematic review. Part 2: perioperative management, multimodal therapies, new technologies, standardization of the surgical treatment and educational aspects. Updates Surg 2020;72:355-78. [PMID: 32306277 DOI: 10.1007/s13304-020-00771-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD, Zhao HL, Peng CW, Yang GF, Li Y. Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases. Oncol Lett 2013;6:1693-700. [PMID: 24260064 DOI: 10.3892/ol.2013.1615] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
46 Lee HS, Lee HE, Yang HK, Kim WH. Perigastric tumor deposits in primary gastric cancer: implications for patient prognosis and staging. Ann Surg Oncol. 2013;20:1604-1613. [PMID: 23184289 DOI: 10.1245/s10434-012-2692-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
47 Zhou R, Wu Z, Zhang J, Wang H, Su Y, Huang N, Shi M, Bin J, Liao Y, Liao W. Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer. Oncotarget 2016;7:1029-41. [PMID: 26556854 DOI: 10.18632/oncotarget.6009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
48 Zhang H, Wang W, Diao D, Cheng Y, Song Y, Zhu K, Dang C. Ratio of metastatic to examined lymph nodes, a helpful staging system and independent prognostic factor of esophagogastric junction cancer. PLoS One. 2013;8:e73238. [PMID: 23977381 DOI: 10.1371/journal.pone.0073238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
49 Agnes A, Biondi A, Cananzi FM, Rausei S, Reddavid R, Laterza V, Galli F, Quagliuolo V, Degiuli M, D'Ugo D, Persiani R. Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study. J Surg Oncol 2019;119:948-57. [PMID: 30742308 DOI: 10.1002/jso.25411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
50 Zhang J, Zou S, Luo R, Zhu Z, Wang Z, Xu H, Huang B. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis? Clin Transl Oncol. 2019;. [PMID: 30977046 DOI: 10.1007/s12094-019-02103-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
51 Ke B, Song XN, Liu N, Zhang RP, Wang CL, Liang H. Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection. PLoS One. 2014;9:e96455. [PMID: 24811256 DOI: 10.1371/journal.pone.0096455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
52 You H, Yang J, Liu Q, Tang L, Bu Q, Pan Z, Lyu J. The impact of the lymph node density on overall survival in patients with Wilms' tumor: a SEER analysis. Cancer Manag Res 2018;10:671-7. [PMID: 29670401 DOI: 10.2147/CMAR.S163514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
53 Kano K, Yamada T, Yamamoto K, Komori K, Watanabe H, Hara K, Shimoda Y, Maezawa Y, Fujikawa H, Aoyama T, Tamagawa H, Yamamoto N, Cho H, Shiozawa M, Yukawa N, Yoshikawa T, Morinaga S, Rino Y, Masuda M, Ogata T, Oshima T. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer. Ann Surg Oncol 2020;27:4235-47. [PMID: 32424582 DOI: 10.1245/s10434-020-08616-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
54 Chang SC, Liu KH, Hung CY, Tsai CY, Hsu JT, Yeh TS, Chen JS, Kuo YC, Hung YS, Chou WC. Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery. J Cancer 2018;9:81-91. [PMID: 29290772 DOI: 10.7150/jca.21989] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
55 Liu J, Geng Q, Chen S, Liu X, Kong P, Zhou Z, Zhan Y, Xu D. Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy. Oncotarget 2016;7:37556-65. [PMID: 27121054 DOI: 10.18632/oncotarget.8788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
56 Deng J, Liang H, Wang D, Sun D, Ding X, Pan Y, Liu X. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol. 2010;17:1043-1051. [PMID: 20039218 DOI: 10.1245/s10434-009-0863-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
57 Mulder KE, Ahmed S, Davies JD, Doll CM, Dowden S, Gill S, Gordon V, Hebbard P, Lim H, McFadden A, McGhie JP, Park J, Wong R. Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015. Curr Oncol. 2016;23:425-434. [PMID: 28050139 DOI: 10.3747/co.23.3384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Tseros EA, Gebski V, Morgan GJ, Veness MJ. Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ann Surg Oncol 2016;23:1693-8. [DOI: 10.1245/s10434-015-5070-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
59 Zaidi MY, Lopez-Aguiar AG, Dillhoff M, Beal E, Poultsides G, Makris E, Rocha F, Crown A, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Barrett JR, Fields RC, Davidson J, Cardona K, Maithel SK. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors. JAMA Surg. 2019;154:134-140. [PMID: 30383112 DOI: 10.1001/jamasurg.2018.3865] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
60 Xu D, Huang Y, Geng Q, Guan Y, Li Y, Wang W, Yuan S, Sun X, Chen Y, Li W, Zhou Z, Zhan Y. Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One 2012;7:e38681. [PMID: 22723875 DOI: 10.1371/journal.pone.0038681] [Cited by in Crossref: 28] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
61 You Y, Shin YC, Choi DW, Heo JS, Shin SH, Kim N, Jang KT, Kim H, Lim CS, Chang SH, Han KM, Han IW. Proposed Modification of Staging for Distal Cholangiocarcinoma Based on the Lymph Node Ratio Using Korean Multicenter Database. Cancers (Basel) 2020;12:E762. [PMID: 32213853 DOI: 10.3390/cancers12030762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Hung YS, Chang SC, Liu KH, Hung CY, Kuo YC, Tsai CY, Hsu JT, Yeh TS, Chen JS, Chou WC. A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification. Asian J Surg 2019;42:85-92. [PMID: 29248301 DOI: 10.1016/j.asjsur.2017.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
63 Geng QR, Xu DZ, He LJ, Lu JB, Zhou ZW, Zhan YQ, Lu Y. Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer. PLoS One 2012;7:e45968. [PMID: 23029344 DOI: 10.1371/journal.pone.0045968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
64 Liu H, Deng J, Zhang R, Hao X, Jiao X, Liang H. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer. International Journal of Surgery 2013;11:419-24. [DOI: 10.1016/j.ijsu.2013.03.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
65 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
66 Yu C, Ying Z, Chen W. The Impact of Calculation Procedure on the Hazard Ratio of N Classifications. Ann Surg Oncol 2011;18:209-10. [DOI: 10.1245/s10434-011-1817-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
67 Aurello P, Catracchia V, Petrucciani N, D'angelo F, Leonardo G, Picchetto A, Antolino L, Magistri P, Terrenato I, Lauro A, Ramacciato G. What is the Role of Nodal Ratio as a Prognostic Factor for Gastric Cancer Nowadays? Comparison with New TNM Staging System and Analysis According to the Number of Resected Nodes. The American Surgeon 2013;79:483-91. [DOI: 10.1177/000313481307900523] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
68 Erstad DJ, Blum M, Estrella JS, Das P, Minsky BD, Ajani JA, Mansfield PF, Ikoma N, Badgwell BD. Benchmarks for nodal yield and ratio for node-positive gastric cancer. Surgery 2021:S0039-6060(21)00398-6. [PMID: 34059344 DOI: 10.1016/j.surg.2021.04.026] [Reference Citation Analysis]
69 Tóth D, Bíró A, Varga Z, Török M, Árkosy P. Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary. Chin J Cancer Res 2017;29:323-32. [PMID: 28947864 DOI: 10.21147/j.issn.1000-9604.2017.04.05] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Qiu HB, Zhang LY, Keshari RP, Wang GQ, Zhou ZW, Xu DZ, Wang W, Zhan YQ, Li W. Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer 2010;10:374. [PMID: 20637122 DOI: 10.1186/1471-2407-10-374] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
71 Xiao LB, Yu JX, Wu WH, Xu FF, Yang SB. Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 2011; 17(46): 5123-5130 [PMID: 22171148 DOI: 10.3748/wjg.v17.i46.5123] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
72 Uña E. Gastric cancer: predictors of recurrence when lymph-node dissection is inadequate. World J Surg Oncol 2009;7:69. [PMID: 19761613 DOI: 10.1186/1477-7819-7-69] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
73 Eom BW, Joo J, Kim Y, Park B, Park JY, Yoon HM, Lee JH, Ryu KW. Is There Any Role of Additional Retropancreatic Lymph Node Dissection on D2 Gastrectomy for Advanced Gastric Cancer? Ann Surg Oncol 2013;20:2669-75. [DOI: 10.1245/s10434-013-2938-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
74 Xu DZ, Geng QR, Tian Y, Cai MY, Fang XJ, Zhan YQ, Zhou ZW, Li W, Chen YB, Sun XW. Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer. BMC Cancer. 2010;10:536. [PMID: 20929525 DOI: 10.1186/1471-2407-10-536] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
75 Peng CW, Wang LW, Fang M, Yang GF, Li Y, Pang DW. Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer. J Transl Med 2013;11:153. [PMID: 23787075 DOI: 10.1186/1479-5876-11-153] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
76 Xu DZ. The lymph node ratio staging system in gastric cancer. Ann Surg Oncol 2010;17:659. [PMID: 19888633 DOI: 10.1245/s10434-009-0793-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
77 Yu CJ, He WT, Liu P. Relationship between the prognostic accuracy of metastatic lymph node ratio and the number of retrieved nodes. Ann Surg Oncol 2011;18 Suppl 3:S216-7. [PMID: 21207156 DOI: 10.1245/s10434-010-1525-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Agnes A, Biondi A, Laurino A, Persiani R, D'Ugo D. Global updates in the treatment of gastric cancer: a systematic review. Part 1: staging, classification and surgical treatment. Updates Surg 2020;72:341-53. [PMID: 32157635 DOI: 10.1007/s13304-020-00736-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
79 Luu C, Thapa R, Woo K, Coppola D, Almhanna K, Pimiento JM, Chen DT, Marquez DD, Hodul PJ. Does histology really influence gastric cancer prognosis? J Gastrointest Oncol 2017;8:1026-36. [PMID: 29299363 DOI: 10.21037/jgo.2017.09.08] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
80 Yamashita K, Hosoda K, Ema A, Watanabe M. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Eur J Surg Oncol 2016;42:1253-60. [PMID: 27017273 DOI: 10.1016/j.ejso.2016.03.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]